glp-1 news today 2025 Shortage = Over GLP-1 Weight-Loss Drug Demonstration Begins

Enjoy the natural, refreshing taste of yuzu in every gummy

Gastrointestinal (GI) adverse eventsparticularly nausea, vomiting, diarrhea, and constipationare the most common side effects, generally emerging during dose escalation and resolving over time

Key Findings: - Increased risk of going over recommended weight gain limits - Higher chances of preterm birth (from 13% to 17%) - Rising cases of gestational diabetes (15% to 20%) - Nearly half faced high blood pressure issues While baby sizes and C-section rates remained similar, the impact on maternal health is significant

Both cohorts were followed until 29 March 2021

The move could significantly expand access to these treatments for people with diabetes and obesity.